by JALR | Jan 5, 2019 | Blog
Pancreatic Cancer Patients Who Participate in Clinical Research Have Better OutcomesMANHATTAN BEACH, Calif., Jan. 3, 2019 /PRNewswire/ –This January, in recognition of National Pancreatic Cancer Clinical Trials Awareness Month, the Pancreatic Cancer Action...
by JALR | Jan 2, 2019 | Blog
LEXINGTON, Ky. (Jan. 3, 2019) — In an editorial published in CNS Spectrums, Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).Noting that...